Further evidence supporting this inverse correlation between BRG1 and EGFR was obtained from a panel of NSCLC cell lines characterized by varying mutational status of the two proteins, as well as from immunostaining of treatment-naïve lung tumor tissue microarrays (TMAs). The gene discussed is SMARCA4; the disease is non-small cell lung carcinoma.